Pivmecillinam Related Products


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Pivmecillinam, pharmacopeial and non-pharmacopeial Pivmecillinam impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Pivmecillinam impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Pivmecillinam-related products are thoroughly characterized. Pivmecillinam products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Pivmecillinam EP Impurity A

SZ目录编号:: SZ-P020002
CAS 号: NA
分子式: C14H22N2O5S : C7H8O3S
分子量: 330.4 : 172.2
投资状态: In Stock

Pivmecillinam EP Impurity B

SZ目录编号:: SZ-P020003
CAS 号: NA
分子式: C21H35N3O6S
分子量: 457.6
投资状态: Out of Stock, Custom Synthesis

Pivmecillinam EP Impurity C

SZ目录编号:: SZ-P020004
CAS 号: NA
分子式: C20H35N3O4S
分子量: 413.6
投资状态: Out of Stock

Pivmecillinam

SZ目录编号:: SZ-P020001
CAS 号: 32887-03-9
分子式: C21H33N3O5S : HCl
分子量: 439.6 : 36.5
投资状态: Custom Synthesis
Rel. CAS No: 32886-97-8 (free base)

Pivmecillinam EP Impurity D

SZ目录编号:: SZ-P020005
CAS 号: NA
分子式: C21H35N3O6S
分子量: 457.6
投资状态: Custom Synthesis

Pivmecillinam Impurity 1

SZ目录编号:: SZ-P020006
CAS 号: NA
分子式: C15H25N3O4S
分子量: 343.4
投资状态: Custom Synthesis

Pivmecillinam Impurity 2

SZ目录编号:: SZ-P020007
CAS 号: NA
分子式: C24H37N5O8S2
分子量: 587.7
投资状态: Custom Synthesis

Pivmecillinam Impurity 3

SZ目录编号:: SZ-P020008
CAS 号: NA
分子式: C24H35N5O7S2
分子量: 569.7
投资状态: Custom Synthesis

Pivmecillinam Impurity 4

SZ目录编号:: SZ-P020009
CAS 号: 875216-88-9
分子式: C9H12N2O4S
分子量: 244.3
投资状态: Custom Synthesis

Pivmecillinam Impurity 5

SZ目录编号:: SZ-P020010
CAS 号: NA
分子式: C14H25N3O2S
分子量: 299.4
投资状态: Custom Synthesis
categories